Concentrations	6 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]
Concentrations	Note 16 – Concentrations Concentration of Credit Risk Financial instruments, which potentially subject the Company to a concentration of credit risk for the years, consist principally of temporary cash investments. There have been no losses in these accounts through June 30, 2023 and the year ended on December 31, 2022. Liquidity risk The Company has an accumulated deficit of $314,747,007 and has a working capital deficit of $30,698,032 as of June 30, 2023, which raises substantial doubt about its ability to continue as a going concern as the Company does not have sufficient funds to discharge its current liabilities. Customers Sales for both the period ended June 30, 2023 and 2022 were $349,204 and $614,951. The Consulting income from related party for the period ended June 30, 2023 and 2022 was $0 and $45,000.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 275
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//275/tableOfContent

Name:	us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration